ARCHIVES

RG7204 Meets Endpoints Of Extending Survival, PFS

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Missouri, Michigan Program As For Comprehensive Review

September 23, 1977

September issue of Business & Regulatory Report included (8-page issue).

October 4, 2002

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Judge Hears Arguments In Fisher’s Privacy Act Suit Over Databases

January 19, 1996

NCI Intends To Extend OSCC Two More Years

October 3, 1986

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998